Enzymotec (Enzymotec) Days Sales Outstanding : 73.70 (As of Sep. 2017)

View and export this data going back to 2013. Start your Free Trial

What is Enzymotec Days Sales Outstanding?

Enzymotec's average Accounts Receivable for the three months ended in Sep. 2017 was $11.04 Mil. Enzymotec's Revenue for the three months ended in Sep. 2017 was $13.67 Mil. Hence, Enzymotec's Days Sales Outstanding for the three months ended in Sep. 2017 was 73.70.

The historical rank and industry rank for Enzymotec's Days Sales Outstanding or its related term are showing as below:

ENZY's Days Sales Outstanding is not ranked ^*
in the Biotechnology industry.
Industry Median: 72.43
* Ranked among companies with meaningful Days Sales Outstanding only.

Enzymotec's Days Sales Outstanding declined from Sep. 2016 (110.95) to Sep. 2017 (73.70).

Enzymotec Days Sales Outstanding Historical Data

The historical data trend for Enzymotec's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzymotec Days Sales Outstanding Chart

Enzymotec Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Days Sales Outstanding

Get a 7-Day Free Trial

88.89

91.93

135.45

102.82

95.63

Enzymotec Quarterly Data
	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17
Days Sales Outstanding	Get a 7-Day Free Trial															110.95	106.73	80.00	79.08	73.70

Competitive Comparison of Enzymotec's Days Sales Outstanding

For the Biotechnology subindustry, Enzymotec's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Enzymotec's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Enzymotec's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Enzymotec's Days Sales Outstanding falls into.

Enzymotec Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Enzymotec's Days Sales Outstanding for the fiscal year that ended in Dec. 2016 is calculated as

	Days Sales Outstanding (A: Dec. 2016 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2015 )	+	Accounts Receivable (A: Dec. 2016 ))	/	count )	/	Revenue (A: Dec. 2016 )	*	Days in Period
=	( (14.956	+	10.038)	/	2 )	/	47.696	*	365
=	12.497					/	47.696	*	365
=	95.63

Enzymotec's Days Sales Outstanding for the quarter that ended in Sep. 2017 is calculated as:

	Days Sales Outstanding (Q: Sep. 2017 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2017 )	+	Accounts Receivable (A: Sep. 2017 ))	/	count )	/	Revenue (A: Sep. 2017 )	*	Days in Period
=	( (11.562	+	10.524)	/	2 )	/	13.672	*	365 / 4
=	11.043					/	13.672	*	365 / 4
=	73.70

Enzymotec (NAS:ENZY) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Enzymotec Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Enzymotec's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Enzymotec (Enzymotec) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Enzymotec Ltd (NAS:ENZY) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.enzymotec.com

Enzymotec Ltd is nutritional and food ingredients company. It develops and manufactures nutritional ingredients and medical foods based on proprietary technologies. Its product portfolio includes Infat, K-Real, Enzy PS solutions, Vayacog, Vayarin and Vayaroll. The company has Nutrition and Vaya Pharma reportable segments. It derives majority of its revenues from Nutrition segment. The firm mainly operates in America, Europe, Australia, Asia, and Israel.

Enzymotec (Enzymotec) Headlines

From GuruFocus

Julian Robertson Adds to Multiple Positions in 3rd quarter

By Tiziano Frateschi Tiziano Frateschi • 12-20-2016

Julian Robertson Cuts Half of Stake in Paulson-Backed Company

By Holly LaFon Holly LaFon • 07-01-2016

Tiger Management Founder Julian Robertson Ups Stake in Enzymotec

By Kyle Ferguson Kyle Ferguson • 12-07-2015